Compare FBRT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRT | NPCE |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | 223 | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.5M | 537.0M |
| IPO Year | N/A | 2021 |
| Metric | FBRT | NPCE |
|---|---|---|
| Price | $7.74 | $13.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $11.50 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 1.1M | 172.4K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | $12.34 | $0.90 |
| Revenue Next Year | $4.95 | $24.46 |
| P/E Ratio | $13.56 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $7.35 | $7.56 |
| 52 Week High | $11.84 | $19.60 |
| Indicator | FBRT | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 36.73 |
| Support Level | N/A | $12.52 |
| Resistance Level | $8.41 | $13.81 |
| Average True Range (ATR) | 0.25 | 0.75 |
| MACD | -0.02 | -0.27 |
| Stochastic Oscillator | 28.12 | 22.10 |
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.